4.7 Article

Update in TSH Receptor Agonists and Antagonists

Journal

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 97, Issue 12, Pages 4287-4292

Publisher

ENDOCRINE SOC
DOI: 10.1210/jc.2012-3080

Keywords

-

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [Z01 DK011006, Z01 DK047044]

Ask authors/readers for more resources

The physiological role of the TSH receptor (TSHR) as a major regulator of thyroid function is well understood, but TSHRs are also expressed in multiple normal extrathyroidal tissues, and the physiological roles of TSHRs in these tissues are unclear. Moreover, TSHRs play a major role in several pathological conditions including hyperthyroidism, hypothyroidism, and thyroid tumors. Small molecule, drug-like TSHR agonists, neutral antagonists, and inverse agonists may be useful as probes of TSHR function in extrathyroidal tissues and as leads to develop drugs for several diseases of the thyroid. In this Update, we review the most recent findings regarding the development and use of these small molecule TSHR ligands. (J Clin Endocrinol Metab 97: 4287-4292, 2012)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available